Bennecib M, Gong C X, Grundke-Iqbal I, Iqbal K
New York State Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314-6399, USA.
FEBS Lett. 2001 Feb 9;490(1-2):15-22. doi: 10.1016/s0014-5793(01)02127-5.
The regulation of the activity of CaMKII by PP-1 and PP-2A, as well as the role of this protein kinase in the phosphorylation of tau protein in forebrain were investigated. The treatment of metabolically active rat brain slices with 1.0 microM okadaic acid (OA) inhibited approximately 65% of PP-2A and had no significant effect on PP-1 in the 16000xg tissue extract. Calyculin A (CL-A), 0.1 microM under the same conditions, inhibited approximately 50% of PP-1 and approximately 20% of PP-2A activities. In contrast, a mixture of OA and CL-A practically completely inhibited both PP-2A and PP-1 activities. The inhibition of the two phosphatase activities or PP-2A alone resulted in an approximately 2-fold increase in CaMKII activity and an approximately 8-fold increase in the phosphorylation of tau at Ser 262/356 in 60 min. Treatment of the brain slices with KN-62, an inhibitor of the autophosphorylation of CaMKII at Thr 286/287, produced approximately 60% inhibition in CaMKII activity and no significant effect on tau phosphorylation at Ser 262/356. The KN-62-treated brain slices when further treated with OA and CL-A did not show any change in CaMKII activity. In vitro, both PP-2A and PP-1 dephosphorylated tau at Ser 262/356 that was phosphorylated with purified CaMKII. These studies suggest (i) that in mammalian forebrain the cytosolic CaMKII activity is regulated mainly by PP-2A, (ii) that CaMKII is the major tau Ser 262/356 kinase in brain, and (iii) that a decrease in PP-2A/PP-1 activities in the brain leads to hyperphosphorylation of tau not only by inhibition of its dephosphorylation but also by promoting the CaMKII activity.
研究了蛋白磷酸酶-1(PP-1)和蛋白磷酸酶-2A(PP-2A)对CaMKII活性的调节作用,以及该蛋白激酶在前脑tau蛋白磷酸化中的作用。用1.0微摩尔冈田酸(OA)处理代谢活跃的大鼠脑片,在16000xg组织提取物中,约65%的PP-2A活性受到抑制,而对PP-1没有显著影响。在相同条件下,0.1微摩尔的花萼海绵诱癌素A(CL-A)可抑制约50%的PP-1活性和约20%的PP-2A活性。相反,OA和CL-A的混合物几乎完全抑制了PP-2A和PP-1的活性。两种磷酸酶活性或单独的PP-2A活性受到抑制后,在60分钟内,CaMKII活性增加约2倍,tau蛋白在Ser 262/356位点的磷酸化增加约8倍。用KN-62(一种CaMKII在Thr 286/287位点自磷酸化的抑制剂)处理脑片,CaMKII活性受到约60%的抑制,而对tau蛋白在Ser 262/356位点的磷酸化没有显著影响。用KN-62处理过的脑片再用OA和CL-A处理后,CaMKII活性没有任何变化。在体外,PP-2A和PP-1均可使经纯化的CaMKII磷酸化的tau蛋白在Ser 262/356位点去磷酸化。这些研究表明:(i)在哺乳动物前脑中,胞质CaMKII活性主要受PP-2A调节;(ii)CaMKII是脑中tau蛋白Ser 262/356位点的主要激酶;(iii)脑中PP-2A/PP-1活性降低不仅通过抑制tau蛋白的去磷酸化,还通过促进CaMKII活性导致tau蛋白过度磷酸化。